Human immunodeficiency virus type 2 infections in Austria

被引:2
|
作者
Taylor, Ninon [1 ]
Kern, Jan Marco [2 ]
Prammer, Wolfgang [3 ]
Lang, Alois [4 ]
Haas, Bernhard [5 ]
Gisinger, Martin [6 ]
Zangerle, Robert [6 ]
Egle, Alexander [1 ]
Greil, Richard [1 ]
Oberkofler, Hannes [7 ]
Eberle, Josef [8 ]
机构
[1] Paracelsus Med Univ, Hosp Salzburg, Lab Immunol & Mol Canc Res, Oncol Ctr,Dept Internal Med Hematol 3, A-5020 Salzburg, Austria
[2] Paracelsus Med Univ, Hosp Salzburg, Hyg & Microbiol Dept, A-5020 Salzburg, Austria
[3] Acad Teaching Hosp Wels Grieskirchen, Dept Microbiol, Wels, Austria
[4] Acad Teaching Hosp Feldkirch, Dept Internal Med, Feldkirch, Austria
[5] Acad Teaching Hosp Graz West, Dept Internal Med, Graz, Austria
[6] Univ Innsbruck Hosp, Dept Dermatol, A-6020 Innsbruck, Austria
[7] Paracelsus Med Univ Salzburg, Dept Lab Med, Salzburg, Austria
[8] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany
关键词
HIV-2; HIV-1/HIV-2; coinfection; Epidemiology; Diagnosis; HIV TYPE-2; VIRAL LOAD; PHYLOGENIES; DIAGNOSES;
D O I
10.1007/s00508-013-0493-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The first case of human immunodeficiency virus type 2 (HIV-2) seropositivity in Austria was confirmed in 1993 in a dually human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected patient from Ghana, who died in 2001. Before this investigation, no further HIV-2 infection was published. The aim of this study was to describe HIV-2 epidemiology in Austria, using serological and molecular techniques, and to perform a sequence analysis of the circulating viral strains. Six additional cases of HIV-2 were identified from 2000 to 2009. All patients originated from high-prevalence areas. In one patient, the HIV-2 infection was revealed 11 years after initial HIV-1 diagnosis, and further analysis confirmed a dual infection. The HIV-2 epidemic has its epicentre in West Africa, but sociocultural issues, especially migration, are contributing to the low but continuous worldwide spread of HIV-2. Diagnosis of HIV-2 implies a different therapeutical management to avoid treatment failure and clinical progression. Differential diagnosis of HIV-1 and HIV-2 is complicated due to antibody cross-reactivity, and paradoxical findings (e.g. declining CD4 cell count despite HIV-1 suppression) may require careful reassessment, especially in patients from endemic countries.
引用
收藏
页码:212 / 216
页数:5
相关论文
共 50 条
  • [1] Human immunodeficiency virus type 2 and human T-cell lymphotropic virus type 1 and type 2 infections in Spain: an update
    Toro, Carlos
    Soriano, Vicente
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (07): : 377 - 379
  • [2] Human immunodeficiency virus type 2
    Reeves, JD
    Doms, RW
    JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 1253 - 1265
  • [3] Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2
    Biberfeld, G
    Thorstensson, R
    Putkonen, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (05) : 443 - 446
  • [4] Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections
    Cole, KS
    Murphey-Corb, M
    Narayan, O
    Joag, SV
    Shaw, GM
    Montelaro, RC
    JOURNAL OF VIROLOGY, 1998, 72 (10) : 7852 - 7859
  • [5] Natural variation of the nef gene in human immunodeficiency virus type 2 infections in Portugal
    Padua, E
    Jenkins, A
    Brown, S
    Bootman, J
    Paixao, MT
    Almond, N
    Berry, N
    JOURNAL OF GENERAL VIROLOGY, 2003, 84 : 1287 - 1299
  • [6] CONTINUED MONITORING FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTIONS IN CALIFORNIA
    BUSCH, MP
    TOBLER, L
    SCHABLE, C
    PETERSEN, L
    TRANSFUSION, 1992, 32 (09) : 873 - 873
  • [7] DOUBLE INFECTIONS WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND TYPE-2 IN SPANISH SUBJECTS
    GORRINO, MT
    MATEOS, MM
    SARRIA, L
    CISTERNA, R
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (12) : 1118 - 1119
  • [8] PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 INFECTIONS IN NIGERIA
    OLALEYE, OD
    BERNSTEIN, L
    EKWEOZOR, CC
    SHENG, ZJ
    OMILABU, SA
    LI, XY
    SULLIVANHALLEY, J
    RASHEED, S
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03): : 710 - 714
  • [9] Infections due to human immunodeficiency virus type 2 and human T-Iymphotropic viruses in Spain
    Trevino, Ana
    Soriano, Vicente
    MEDICINA CLINICA, 2014, 142 (07): : 323 - 326
  • [10] HUMAN IMMUNODEFICIENCY VIRUS TYPE-2
    HAMMOND, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1989, 140 (02) : 121 - 122